News About: Pharm. Industry
Gilead to launch ‘Zydelig Tab’ in the domestic marketGilead Sciences has acquired a domestic sales approval for Zydelig(generic name: idealisib), a lymphocytic leukemia treatment.
The Ministry of Food and Drug Safety approved sal...
|
Status of improved new drugs and generics in a year of Nexium patent expiration
It has been over a year since the patent of Nexium(esomeprazole), a leading antiulcer drug, was expired. The Nexium market has met a large change after the entry of generics.
Before the patent expiration, in fact, Ne...
Official establishment of Amgen Korea, “We will focus on new drug launches”Amgen Korea has shown a plan to enlarge domestic investment in clinical trials and to strengthen its new drug pipeline as officially established.
On the 3rd, Amgen Korea announ...
|
‘R&D Cooperation-Technology Exchange’ for domestic and multinational pharmaceuticals
An opportunity will be created for global pharmaceutical companies to share cooperative strategies for open innovations and establish global partnerships with domestic pharmaceutical companies for joint growths. The o...
Different positions of BMS, Gilead and Abbvie over hepatitis C guidelineDisease guidelines are important to pharmaceutical companies. They can be even more important for recently-launched drugs.
This is why the industry has paid attention to the he...
|
Domestic pharmaceutical companies as Central & South America Health Medical Mission
The 2015 Central & South America Health Medical Mission, which is scheduled to be dispatched within this month, will be participated by 3 domestic pharmaceutical companies.
It was known Daewoong Pharmaceutical, Korea...
Ilyang Pharmaceutical’s new ‘ER—GMP level’ factory for SupectIlyang Pharmaceutical(CEO Dong-yeon Kim) had a ceremony for completion of a manufacturing facility exclusively for “Supect,” a chronic myeloid leukemia, at the BioValley located...
|
Improvement plan for Domestic biosimilar drug assessment to be finalized
As the government included the biopharmaceutical industry in the target for the relaxation policy of regulation, the Ministry of Health and Welfare(MOHW) is planning to finalize the improvement plan for drug price ass...
Stock prices of 10 pharmaceuticals increased by more than 200%
It was observed stocks of listed pharmaceutical companies were increased by more than 100% compared with the late last-year.
Particularly, stocks of 10 companies, such as Hanmi Science, Samsung Pharm and Hanmi Pharm,...
Ahngook Pharm’s osteoporosis treatment, ‘Binosto Effervescent Tab’ to be approvedAhngook Pharm(President Uh Jin) has completed domestic approval of Binosto Effervescent Tab(alendronate sodium 70mg), a bisphosphonate-type osteoporosis treatment, on Oct. 14.
...
|
